{
    "Trade/Device Name(s)": [
        "Borrelia burgdorferi B31 IgG Line Blot Test Kit",
        "Borrelia burgdorferi IgG B31 Line Blot Test Kit"
    ],
    "Submitter Information": "Gold Standard Diagnostics",
    "510(k) Number": "K113847",
    "Predicate Device Reference 510(k) Number(s)": [
        "K950829"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSR"
    ],
    "Summary Letter Date": "December 28, 2011",
    "Summary Letter Received Date": "January 18, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3830"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "immunology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Borrelia burgdorferi"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Line blot",
        "Western blot",
        "Immunoassay"
    ],
    "Methodologies": [
        "Antigen-antibody detection",
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Borrelia burgdorferi B31 IgG Line Blot Test Kit for qualitative detection of IgG antibodies to B. burgdorferi in human serum",
    "Indications for Use Summary": "For qualitative detection of IgG antibodies to B. burgdorferi sensu stricto (B31) in human serum, intended for samples found positive or equivocal by ELISA or IFA to provide supportive evidence of infection",
    "fda_folder": "Microbiology"
}